San Diego, CA, United States of America

Jason Edward Wallace

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jason Edward Wallace: Innovator in Clinical Trial Technology

Introduction

Jason Edward Wallace is a notable inventor based in San Diego, California. He has made significant contributions to the field of clinical trials through his innovative approaches and patented technologies. With a total of two patents to his name, Wallace is recognized for his work in enhancing the efficiency and effectiveness of clinical trial processes.

Latest Patents

Wallace's latest patents focus on intelligent planning, execution, and reporting of clinical trials. These patents introduce machine learning-based methods that incorporate a patient burden index. One aspect of his invention involves a method for determining a patient burden index, which includes parsing a protocol for a clinical trial. The method further entails providing factor data for each of a plurality of patients. Additionally, it calculates a patient burden index for each patient based on the parsed protocol and the provided factor data.

Career Highlights

Throughout his career, Jason Edward Wallace has worked with prominent companies in the industry, including Trials.ai, Inc. and ZS Associates, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in clinical trial methodologies.

Collaborations

Wallace has collaborated with several professionals in his field, including Kim Marie Walpole and Michael Joseph Nicoletti. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

In summary, Jason Edward Wallace is a distinguished inventor whose work in clinical trial technology has the potential to transform the industry. His innovative patents and collaborative efforts highlight his commitment to improving clinical trial processes for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…